Merck moves to seal $53-a-share takeover of Terns Pharmaceuticals
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Opioid dependence remains a major driver of death and disease worldwide
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The financing includes a four-year interest-only period, extendable to five years if a net sales milestone is achieved
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
New adult supplement combines 26 vitamins, minerals and botanicals to address stress, energy, immunity and cognitive wellness in one daily tablet
Subscribe To Our Newsletter & Stay Updated